Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
Seattle, Washington
Details of the presentations are as follows:
Title: Phase 1 Safety, Tolerability and Pharmacokinetic Study of Topical Ocular CB1 Agonist,
SBI-100 A Novel Prodrug of THC, in Healthy Volunteers
Posterboard Number: B0267
Date and Time: Monday, May 6, 2024, at 8:30-10:15 a.m. PDT
Location: Exhibit Hall - Seattle Convention Center
Presenter: Tu Diep, MSc, Chief Development Officer of Skye
Title: Development and screening of a novel library of synthetic endocannabinoid agonists and inhibitors to advance a potential therapy to treat dry eye disease and chronic ocular pain
Posterboard Number: B0328
Date and Time: Thursday, May 9, 2024, at 8:00-9:45 a.m. PDT
Location: Exhibit Hall - Seattle Convention Center
Presenter: Chris Twitty, PhD, Chief Scientific Officer of Skye